Drug Type Prophylactic vaccine |
Synonyms 冻干人用狂犬病疫苗(Vero细胞)(长春卓谊生物股份有限公司) |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (23 Nov 2016), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Rabies | CN | 23 Nov 2016 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Human Papillomavirus Infection | Preclinical | CN | 31 Dec 2023 |
NCT05549908 (Pubmed) Manual | Phase 3 | 1,800 | (nmkwvbvjjh) = The overall incidence of adverse events showed no significant difference between the four-dose test group and the five-dose control group, but was significantly lower in the four-dose test group compared to the four-dose control group kvjtcfsyos (tvhiwmkchd ) View more | Positive | 26 Jun 2024 | ||